Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series

Trastuzumab-based regimes improved clinical outcome in women with overexpressing HER2 metastatic breast cancer, mainly due to the availability of different combination therapies, clinically active and well tolerated. In this study we retrospectively evaluated clinical activity and toxicity of trastu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Di Lauro, Vincenzo, Torrisi, Elena, Bidoli, Ettore, Quitadamo, Daniela, Cecco, Sara, Veronesi, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321447/
https://ncbi.nlm.nih.gov/pubmed/22536237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/198412
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados